title: Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children.
authors: Stollery Children's Hospital, Edmonton, AB, Canada. Lesley.Mitchell@albertahealthservices.ca
authors: L G
authors: LG
authors: Mitchell
authors: N A
authors: NA
authors: Goldenberg
authors: C
authors: C
authors: Male
authors: G
authors: G
authors: Kenet
authors: P
authors: P
authors: Monagle
authors: U
authors: U
authors: Nowak-Göttl
mesh_terms: D002648:Child; D002986:Clinical Trials as Topic / Q000592:standards*; D023381:Endpoint Determination / Q000592:standards; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000517:prevention & control; D012449:Safety; D012955:Societies, Medical; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents